The peptide neuromedin U (NMU) is elevated in NYHA II and III heart failure

ConclusionsNMU is elevated in serum from stage II and III heart failure patients, supporting data from our pre-heart failure animal model; however, further study is needed to determine whether NMU is a reliable biomarker for pre-heart failure.
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Article Source Type: research